The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

Keep Focus on Emerging Infections, Disease X: Analysts

Keep Focus on Emerging Infections, Disease X: Analysts

Research funding for emerging infectious diseases rarely reaches the countries where such diseases do the most harm, according to new data analysis that highlights how…

Attributes and Predictors of Long-COVID

Attributes and Predictors of Long-COVID

Long-COVID is characterized by symptoms of fatigue, headache, dyspnoea and anosmia. At the population level, it is critical to quantify the burden of Long-COVID to…

Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers University of Minnesota Medical School physician researchers studied hydroxychloroquine as a…

Building an ACE2 Receptor Trap for Pandemic Pathogens

Building an ACE2 Receptor Trap for Pandemic Pathogens

Researchers led by the University of California, San Francisco and the University of Alberta, Edmonton have engineered angiotensin-converting enzyme II (ACE2) receptor traps which neutralize…

DoD Leverages Lung-on-a-Chip Technology for COVID-19 Research

DoD Leverages Lung-on-a-Chip Technology for COVID-19 Research

Military units conduct reconnaissance missions to obtain information – by visual observation or other detection methods – about the activities and resources of an enemy.…

Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher

Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher

Centivax Inc, the therapeutics spinout of Contract Research Organization Distributed Bio Inc, announced today a licensing agreement with Thermo Fisher Scientific. Thermo Fisher has developed…

View All Featured News



HEADLINE NEWS

COVID-19 Industry Rivals Plan Joint Pledge on Vaccine Safety

COVID-19 Industry Rivals Plan Joint Pledge on Vaccine Safety

Several drug makers developing vaccines to counter SARS-CoV-2 plan to issue a public pledge not to seek government approval until the shots have proven to…

Thousands of Scientists Denounce ‘Political’ Federal Funding Cuts to EcoHealth Alliance Coronavirus Research

Thousands of Scientists Denounce ‘Political’ Federal Funding Cuts to EcoHealth Alliance Coronavirus Research

In an open letter to a top Trump Administration official, 77 Nobel prize-winning American scientists say they are “gravely concerned” about the recent abrupt cancellation of a…

Thailand Begins Coronavirus Vaccine Trials on Monkeys

Thailand Begins Coronavirus Vaccine Trials on Monkeys

Thailand’s National Vaccine Institute (NVI) at Chulalongkorn University today began testing a trial vaccine against the novel coronavirus on non-human primates after positive trials in…

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

Abbott announced today the launch of its third COVID-19 test, a lab-based serology blood test for the detection of the antibody, IgG, that identifies if a person…

BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent plasma and hyperimmune globulin immunotherapies. These treatments…

BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

BARDA and Vela Diagnostics USA, Inc. are entering into a partnership to develop a rapid diagnostic test for use on two instrument platforms to aid in the…

Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

Ridgeback Biotherapeutics announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for an orally available antiviral compound, EIDD-2801, to begin human testing.  This action…

BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

BARDA is collaborating with DiaSorin to develop a clinical laboratory test to identify people who have been infected with the SARS-COV-2 virus but have recovered. Known as…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa